The feasibility, generalizability, and validity of randomized controlled trials (RCTs) may be compromised when patients have preferences for specific trial arms. The patient preference trial (PPT) design, which assigns at least a subset of the patients based on their preference rather than randomization, has been proposed as an alternative. The aim of this review was to provide an overview of the application of the PPT design in oncological research, with a particular focus on PPTs designed to assess the effectiveness of an intervention and provide recommendations on reporting.

Read the review

Categories

Cancer  Cancer Research General Guidelines  

Tags

nonrandomised  oncology  preference  randomised controlled trial  reporting guidelines  trial  

Reply

Please Sign in (or Register) to view further.